Pandemic Preparedness: Biocontainment Facility Upgrade and Integration at UTMB/Galveston National Laboratory

流行病防范：UTMB/加尔维斯顿国家实验室的生物防护设施升级和集成

• 批准号: 10611097
• 负责人: Gary Kobinger
• 金额: $ 713.18万
• 依托单位: UNIVERSITY OF TEXAS MED BR GALVESTON
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-16 至 2025-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10611097
• 关键词: 2019-nCoV; Address; Africa; African; Air; Algorithms; American Type Culture Collection; Animals; Antigens; Antiviral Agents; Applied Research; Arboviruses; Area; Automation; Award; Basic Science; Biomedical Research; Biotechnology; Bioterrorism; Bunyavirales; COVID-19; COVID-19 pandemic; Carbon Dioxide; Cells; Centers for Disease Control and Prevention (U.S.); Cessation of life; Clinical Research; Clinical Sciences; Collaborations; Collection; Communicable Diseases; Communication; Communities; Complex; Computer Security; Containment; Core Facility; Coronavirus; Country; Culicidae; Dangerousness; Data Storage and Retrieval; Department of Defense; Development; Diagnosis; Diagnostic; Differential Diagnosis; Disease; Disease Outbreaks; Disease Vectors; Drainage procedure; Duct (organ) structure; Ebola; Ebola Vaccines; Ebola virus; Educational process of instructing; Electronics; Emergency Situation; Emerging Communicable Diseases; Ensure; Environment; Environmental Health; Epidemic; Equipment; Evaluation; Exercise; Faculty; Family; Family Picornaviridae; Filovirus; Financial Support; Fire - disasters; Flaviviridae; Foundations; Freezing; Funding; Future; Goals; Government; HIV; Home; Hospitals; Human; Human Resources; Immunity; Infection; Infectious Agent; Infectious Disease Immunology; Infectious Diseases Research; Influenza A Virus, H1N1 Subtype; Influenza A virus; Information Technology; Infrastructure; Institutes; Institution; International; Investigation; Joints; Journals; Laboratories; Laboratory Research; Lead; Leadership; Learning; Letters; Licensure; Maintenance; Malaria; Marburgvirus; Measures; Medical; Medical Research; Medical Staff; Middle East Respiratory Syndrome; Mission; Modeling; Modernization; Modification; National Institute of Allergy and Infectious Disease; Nature; Nurses; Paramyxovirus; Pathogenesis; Pathogenicity; Pharmacologic Substance; Police; Positioning Attribute; Prevention; Prevention approach; Principal Investigator; Privatization; Procedures; Professional Practice; Public Health; Publications; Publishing; RNA; RNA Viruses; Reader; Readiness; Reagent; Recording of previous events; Regulation; Reporting; Research; Research Design; Research Institute; Research Personnel; Research Project Grants; Role; Running; Safety; Science; Scientist; Sea; Security; Services; Ships; Side; Structure; Support System; System; Systems Integration; Techniques; Testing; Texas; Therapeutic; Therapeutic Monoclonal Antibodies; Ticks; Time; Training; Training and Education; Translating; Translational Research; Treatment Efficacy; Tropical Disease; United States; United States Food and Drug Administration; United States National Institutes of Health; Universities; Vaccine Research; Vaccines; Vector-transmitted infectious disease; Veterinarians; Vial device; Viral; Virus; Virus Diseases; Washington; West Nile virus; Work; World Health Organization; Writing; ZIKA; Zaire Ebola virus; Zoonoses; animal model development; animal resource; animal rule; antigen diagnostic; base; bench to bedside; biocontainment facility; biodefense; biopharmaceutical industry; biosafety level 4 facility; biosecurity; chikungunya; combat; communication device; cyber security; diagnostic tool; drug candidate; drug testing; end of life; exhaust; experience; firewall; good laboratory practice; improved; infectious disease treatment; interdisciplinary approach; laboratory experience; medical countermeasure; meetings; mortality; multidisciplinary; next generation; operation; pandemic disease; pandemic influenza; pandemic preparedness; pathogen; practical application; professional atmosphere; public health emergency; repository; research and development; research facility; respiratory virus; response; screening; statistics; therapeutic development; therapeutically effective; transmission process; vaccine development; vector-borne; ventilation; virtual; virus development; weapons

PROJECT SUMMARY/ABSTRACT Toward maintaining and improving pandemic preparedness, we propose value-added facility upgrades that better integrate the high-containment communities at the University of Texas Medical Branch (UTMB), Galveston. UTMB laboratories integrate operations through joint-facility management, usage, and collaborations that include educating the next generation of research scientists and medical staff. The UTMB community contains the Robert E. Shope Laboratory (Shope)—the first full-sized BSL-4 facility within a university in the United States, a structurally separate high-containment Galveston National Laboratory (GNL), and BSL3 laboratories of Mary Moody Northen Pavilion (MMNP). Each facility supports multiple experienced, published, and governmentally-funded investigators researching pathogens with pandemic potential, as well as facilitating biomedical research of vaccines and therapeutics. Our corpus of researchers includes 31 experts in one or more of six out of the seven RNA viruses of focus by NIAID toward Pandemic Preparedness. The requested financial support will enhance facility capabilities and security within an integrated system of services and operational functions that support the mandate of the GNL within the UTMB high-containment community. We propose to enhance integration of systems to provide a comprehensive protection of all UTMB high-containment facilities against cyberattack, while improving workflow, biosafety, biosecurity, and training capacities through modernization of specific antiquated high-containment areas that are also essential to pandemic responsivity. Of priority is to upgrade equipment and supportive infrastructure utilized in high-containment RNA viral research reaching “end-of-life” (EOL) or “end-of-service” (EOS), prior to experiencing difficulties procuring parts or having stoppage resulting in lost time, funds, and mitigating preparedness. Additionally, we will remedy specific infrastructural shortcomings to improve facility operations. Furthermore, as a leader in teaching the future investigators of high-consequence pathogens, the GNL proposes to upgrade a training area to better reflect the actual BSL4 environment. We will meet these goals through three Aims: Aim 1: Integrate cybersecurity systems under the GNL isolated protection, while modernizing safety and security of virtual and physical structures of UTMB high-containment facilities. Aim 2: Modernize facility and equipment of integrated usage among UTMB’s research community directly in support of BSL3 and BSL4 RNA research of viruses with high pandemic or weaponization potential. Aim 3: Implement pandemic preparedness toward effective future strategic response capacity. Ultimately, modernizations and integrations of systems, operations, and training will better position UTMB to contribute as a global research leader in discovery and development of solutions against high- consequence pathogens. This proposal is framed to provide enhanced security and capacities to further support our roles as collaborator, reference center and repository, institutional model, and trainer toward strategic implementation of a global pandemic preparedness.

项目总结/文摘